L A Luong
Overview
Explore the profile of L A Luong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu X, Zhang L, Wen G, Zhao H, Luong L, Chen Q, et al.
Cell Death Differ
. 2014 Dec;
22(7):1170-80.
PMID: 25526086
microRNA-34a (miR-34a) and sirtuin 1 (SirT1) have been extensively studied in tumour biology and longevity/aging, but little is known about their functional roles in smooth muscle cell (SMC) differentiation from...
2.
Kelberman D, Hawe E, Luong L, Mohamed-Ali V, Lundman P, Tornvall P, et al.
Thromb Haemost
. 2004 Nov;
92(5):1122-8.
PMID: 15543342
Elevated plasma IL-6 levels have been implicated in the pathogenesis of coronary heart disease. We have investigated the association of two polymorphisms in the promoter of IL-6 (-572G>C and -174G>C)...
3.
Humphries S, Luong L, Ogg M, Hawe E, Miller G
Eur Heart J
. 2001 Dec;
22(24):2243-52.
PMID: 11728144
Aims: Inflammation is a key component of coronary heart disease, and genes coding for cytokines are candidates for predisposing to coronary heart disease risk. We have examined the effect of...
4.
Rauramaa R, Vaisanen S, Luong L, Schmidt-Trucksass A, Penttila I, Bouchard C, et al.
Arterioscler Thromb Vasc Biol
. 2000 Dec;
20(12):2657-62.
PMID: 11116068
The functional 5A/6A polymorphism of the stromelysin-1 promoter has been implicated as a potential genetic marker for the progression of angiographically determined atherosclerosis in patients with coronary artery disease. Recently,...
5.
Martin R, Luong L, Welsh N, Eglen R, Martin G, MacLennan S
Br J Pharmacol
. 2000 Apr;
129(8):1707-15.
PMID: 10780977
This study investigated the cannabinoid receptor, known to inhibit neuronally-evoked contractions of the mouse isolated urinary bladder, in bladder sections isolated from mouse, rat, dog, pig non-human primate or human....
6.
Hamsten A, Syvanne M, Silveira A, Luong L, Nieminen M, Humphries S, et al.
Thromb Haemost
. 2000 Apr;
83(3):397-403.
PMID: 10744143
Impaired fibrinolytic function, mainly due to increased plasma plasminogen activator inhibitor-1 (PAI-1) activity, is common in patients with manifest coronary artery disease (CAD) and a predictor of recurrent cardiovascular events....
7.
Humphries S, Luong L, Montgomery H, Day I, Mohamed-Ali V, Yudkin J
Thromb Haemost
. 1999 Dec;
82(2):818-25.
PMID: 10605788
No abstract available.
8.
Vaisanen S, Humphries S, Luong L, Penttila I, Bouchard C, Rauramaa R
Thromb Haemost
. 1999 Sep;
82(3):1117-20.
PMID: 10494774
The aim of this controlled randomised clinical trial was to investigate the effects of regular low to moderate intensity physical activity on plasminogen activator inhibitor-1 (PAI-1) activity during three years...
9.
Penno G, Chaturvedi N, Talmud P, Cotroneo P, Manto A, Nannipieri M, et al.
Diabetes
. 1998 Sep;
47(9):1507-11.
PMID: 9726242
We examined whether the ACE gene insertion/deletion (I/D) polymorphism modulates renal disease progression in IDDM and how ACE inhibitors influence this relationship. The EURODIAB Controlled Trial of Lisinopril in IDDM...
10.
Humphries S, Luong L, Talmud P, FRICK M, Kesaniemi Y, Pasternack A, et al.
Atherosclerosis
. 1998 Aug;
139(1):49-56.
PMID: 9699891
The relationship between the 5A/6A stromelysin-1 promoter polymorphism and progression of angiographically determined coronary artery disease (CAD) has been examined in men treated for 32 months with gemfibrozil or placebo...